The investigation focuses whether false and/or misleading statements were made by Legend and/or that Legend failed to disclose pertinent information to investors. A press release was issued by Legend on September 21, 2020, which disclosed that Legend Biotech Corporation CEO Dr. Fangliang Zhang has been placed under residential surveillance by the Chinese government. It was also admitted by Legend that the Chinese Customs Anti-Smuggling Department has inspected the offices of GenScript Biotech Corporation, Legend’s majority shareholder. Facilities inspected included Legend’s offices, and are related to alleged violations of import and export regulations. Shares of Legend fell by more than 17% on the same day, based on this news.
Legend Biotech Corporation
Investors that purchased the Company’s securities and have suffered a loss, please fill in transaction information below, or email to email@example.com.
There is no cost or obligation associated with submitting your information. If you are a shareholder who suffered a loss, please submit your contact information and purchase information to participate in the putative class action.
We also encourage you to contact Lesley F. Portnoy of The Portnoy Law Firm, at 310.692.8883, to discuss your rights free of charge. You can also reach us through the firm’s website at www.portnoylaw.com, or by email at firstname.lastname@example.org.
If you choose to take no action, you can remain an absent class member.
Joining the case through the Portnoy Law website enables investors to learn about their legal claims and take an active role in recovering their losses.
The Portnoy Law Firm represents investors around the world and specializes in securities class action lawsuits and shareholder rights litigation.
Portnoy Law Firm
Lesley F. Portnoy, Esq.,
1800 Century Park East, Suite 600
Los Angeles, CA 90067